School of Medicine
Showing 3,051-3,100 of 12,883 Results
-
Amin Etemad, MBA, SSGB
Quality Programs Manager, Surgery
BioAmin Etemad holds a Bachelor's degree in Management from HEC Montréal and an MBA in Medical Management from the University of St. Thomas in Minneapolis, earned in 2008. He began his career as an Operations Manager at Amazon’s MSP5 fulfillment center in Shakopee, MN, before moving to Allina Health, where he served as a Process Improvement Manager within the supply chain team. Amin later transitioned to a central Quality Improvement role at Allina, where he contributed to Minnesota’s COVID-19 surge planning for the ED and ICU in 2020.
In the fall of 2020, Amin joined Stanford Health as a Quality Improvement Project Manager in Radiology. In 2023, he moved to the School of Medicine, where he now leads the quality improvement team in the Department of Surgery.
Outside of work, Amin is passionate about tennis, soccer, and music—playing both acoustic guitar and a traditional string instrument called the Santoor. He is fluent in five languages, having lived on three continents and in five countries. Raised in a family of over 10 medical professionals, Amin has a deep love for travel, exploring new cultures, and experiencing diverse cuisines. -
Ali Etemadi
Postdoctoral Scholar, Nephrology
Current Research and Scholarly InterestsI am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.
-
Susan Payne Etheridge
Adjunct Clinical Professor, Pediatrics - Cardiology
BioDr. Etheridge is a board-certified pediatric cardiologist and electrophysiologist. Since beginning her tenure in Pediatric Cardiology, her research focus has centered on Long QT Syndrome (LQTS) and other genetic disorders leading to sudden death in the young. She directed local and multi-center collaborative projects concerning LQTS, supraventricular tachycardia and Wolff-Parkinson-White Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia and hypertrophic cardiomyopathy. She has actively participated in multicenter projects of genetic conditions associated with sudden death in the young, including Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Timothy Syndrome, Andersen-Tawil Syndrome, hypertrophic cardiomyopathy, sudden death in athletes, and fetal LQTS. She was the local PI for multicenter projects on hypertrophic cardiomyopathy, fetal and nonfetal LQTS, Wolff-Parkinson-White Syndrome, Timothy Syndrome and CPVT. She is an an invited speaker at local, national, and international meetings where she speaks largely on the genetic susceptibility to sudden death in the young and WPW. She has published book chapters and invited editorials and articles related to heritable sudden death conditions and sports participation and arrhythmias in congential heart disease.
Her experience as a pediatric electrophysiologist, a Fellow in the Heart Rhythm Society, past present of the Pediatric and Congenital Arrhythmia Society, member of the America College of Cardiology Electrophysiology Committee and Vice President of the Sudden Arrhythmia Death Foundation underscores her interest in and service to children and adults with arrhythmic disease. Her years on the American Board of Pediatrics and her past leadership role within the fellowship speak to her dedication to the next generation of pediatric cardiologitsts. Dr. Etheridge created and led the University of Utah Inherited Arrhythmia clinic. This is a collaborative clinic that focuses on children and adults with familial sudden death conditions with input from genetics, adult and pediatric electrophysiology and child psychology. The goal was the pre-symptomatic assessment and sudden death prevention in patients with inherited arrhythmia conditions and care for the child and the entire family. The team followed the nationally defined protocols for this assessment and engage our research, genetics and adult electrophysiology colleagues in this assessment. She is embarking upon a similar role at Stanford University. As the Vice President of the SADS Foundation, she is intimately involved with families with these conditions. She takes part in and has developed educational seminars concerning these conditions as part of her involvement with SADS. She often faces questions concerning sports participation in children and young adults with inherited conditions that put children at risk for sudden death. She is a part of the writing group for a recently published consensus document on return to play with heart conditions from the Heart Rhythm Society, American College of Cardiology and the American Heart Association.
She has dedicated some of her clinical work to the care of adults with arrhytmias in the setting of congenital heart disease and has a clinic for this population in California, Alaska and Idaho. She is scheduled to co-chair the upcoming HRS document on arrhythmia management in adults with congenital heart disease. -
Brady Evans, MD, MBA
Clinical Assistant Professor, Orthopaedic Surgery
Clinical Assistant Professor (By courtesy), Surgery - Plastic & Reconstructive SurgeryBioDr. Evans is an orthopaedic surgeon and a clinical assistant professor of orthopaedic surgery specializing in the treatment of hand and upper extremity conditions. He has extensive training in the full range of orthopaedic treatment approaches, from noninvasive strategies to the most advanced surgical procedures, including peripheral nerve and microvascular surgery.
Among the wide spectrum of conditions that Dr. Evans treats are joint, ligament, and tendon injuries; nerve and vessel disorders; all forms of arthritis; fractures; carpal and cubital tunnel syndrome; and, pediatric and congenital disorders of the hands and upper extremities.
Implementing a comprehensive patient treatment plan usually involves multiple specialists. Dr. Evans collaborates with other team members such as spinal care specialists, rheumatologists, plastic surgeons, and physical and occupational therapists. He also closely coordinates treatment and follow-up with the primary care physicians and emergency medicine physicians, as well as other orthopaedic specialists, who refer patients for his specialized care.
For every patient he sees, he develops a personalized plan of care emphasizing the most conservative treatment possible. The goal of each patient’s care plan is to precisely diagnose the condition, relieve symptoms that may include pain and immobility, and restore use of the affected hand or limb as safely and quickly as possible.
The opportunity to treat diverse, complex conditions from start to finish and help patients return to functionality and mobility are among the key reasons Dr. Evans chose to practice orthopaedic surgery. To help advance his specialty through innovative research initiatives, Dr. Evans has investigated applications of frontier technology such as virtual reality and artificial intelligence to enhance patient care and education. His research interests also include the management of distal radius fractures, surgical decision-making, and costs and outcomes of orthopaedic surgical procedures.
As an author, Dr. Evans has published articles in numerous journals including the Journal of Bone and Joint Surgery, Journal of Pediatric Orthopaedics, Archives of Surgery, Current Reviews in Musculoskeletal Medicine, and others. Article topics range from clinical issues to the financial aspects of care. He also has contributed textbook chapters as the primary author of “Fractures of the Distal Radius and Ulna” in Rockwood and Green’s Fractures in Adults, 9th edition and as an author of “Carpal Tunnel Syndrome After Fractures and Other Trauma” in the 2017 edition of the guide Carpal Tunnel Syndrome. In addition, he is a reviewer for HAND, the official journal of the American Association for Hand Surgery, and for the Journal of Hand Surgery Global Online.
Dr. Evans makes scientific presentations at major national conferences on a variety of topics: resident education, virtual reality in health care, plus various aspects of clinical care.
He has won honors and recognition for his research and scholarship, including the Richard J. Smith Award from Massachusetts General Hospital and Harvard Medical School for the best clinical/translational paper presentation.
Dr. Evans is board-eligible with the American Board of Orthopaedic Surgery and a member of the American Academy of Orthopaedic Surgeons and American Society for Surgery of the Hand. -
Stephanie Allen Evans
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioResume visible at http://bit.ly/EvansResume
This link needs to be copied and pasted into your browser to view. -
Audrey Evers
Casual - Non-Exempt, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Psychology Doctoral Student, PGSP-Stanford PsyD Consortium
Clinical Research Coordinator, Depression Research Clinic -
Sedona Ewbank
Ph.D. Student in Neurosciences, admitted Autumn 2019
Current Research and Scholarly InterestsI am interested in using and developing systems neuroscience approaches to improve understanding and treatment of psychiatric illnesses. My current work is focused on developing translatable, noninvasive deep brain neuromodulation through targeted delivery of psychotropic drugs via ultrasound-sensitive nanoparticles.
-
Markus Eyting
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioI am an applied microeconomist, using experimental methods as well as survey and administrative data to study the interplay of beliefs and individual decision-making with applications to health, discrimination, and machine learning.
For more information, please visit my website: https://meyting.com/. -
Raj Fadadu
Casual - Non-Exempt, Epidemiology and Population Health
BioRaj Fadadu is currently a dermatology resident physician at the University of California, San Diego. He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) as well as epigenetics (e.g., EWAS and epigenetic age acceleration). At Stanford, his research in Dr. Andres Cardenas's group focuses on the relationship between environmental exposures and epigenetic modifications. He also held leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.
He received a M.D. from UC San Francisco, M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health, and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors). -
Muneeb A. Faiq
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioDr. Muneeb A. Faiq is a behavioral and metabolic neuroscientist and ophthalmology researcher whose work spans molecular biology, neuroimaging, and systems neuroscience. He has made several foundational contributions, including the first functional cloning of CYP1B1 in congenital glaucoma, implicating retinoic-acid signaling in Zika virus–associated microcephaly, identifying central insulin resistance as a mechanistic basis for glaucoma, and providing the first in vivo evidence for a glymphatic pathway in the optic nerve. With more than 100 peer-reviewed publications and over 4,000 citations, Dr. Faiq has earned international recognition, including the Emerging Vision Scientist Award – 2019 from the Alliance for Eye and Vision Research. He is widely regarded as the pioneer and principal architect of the discipline of psychosomatic ophthalmology, a field he helped conceptualize and establish, leading to the integration of ophthalmic clinical practice with mindfulness-based and psychosomatic medicine frameworks. Dr. Faiq is currently advancing the concept of neurometabolic syntax in vision and brain function — a unifying systems-level framework that integrates genetics, metabolism, and behavior to reconceptualize ophthalmic and neurological diseases through a mechanistic and interdisciplinary lens. He has been selected for the prestigious Asia Pacific Academy of Ophthalmology (APAO) Achievement Award 2026.
-
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research focuses on musculoskeletal and organ-based ultrasound in rheumatic disease, including arthritis, calcinosis, vascular pathology, and interstitial lung disease. He develops ultrasound-based outcome measures and leads projects applying deep learning and explainable AI to imaging. He also performs ultrasound-guided synovial biopsies to support translational and clinical research.
-
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
BioDr. Bita Fakhri is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford. Additionally, in her role as the DEI ambassador of the Division of Hematology, her main focus is to enhance trial equity among underserved and marginalized populations in the Stanford catchment area.
-
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Ryann Fame, PhD
Assistant Professor of Neurosurgery
Current Research and Scholarly InterestsEarly neural progenitors respond to extrinsic cues that maintain and support their potency. These stem/ progenitor cells are in direct contact with the cerebrospinal fluid (CSF), which acts as part of their niche. Our research program encompasses the early neural stem cell niche, neural tube closure, CSF, metabolism, and cortical neuronal development. We are dedicated to broad collaboration focused on translating an understanding of neurodevelopment and CSF biology into regenerative strategies.
-
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
